Avient (AVNT) Earnings Date & Reports

Key Takeaways

• Avient Corporation (NYSE: AVNT) is scheduled to report third quarter 2026 results before the market opens on Wednesday, November 4, 2026.
• Analysts expect adjusted earnings of roughly $0.80 per share on revenue near $857 million, versus $0.70 per share and $806.5 million in the year-ago quarter.
• Management has guided third quarter adjusted earnings per share (EPS) to approximately $0.80, implying about 14% growth year over year.
• Avient has topped consensus EPS estimates in seven of its last eight quarters, including a strong second quarter 2026 beat of $0.96 versus $0.89 expected.
• Full-year 2026 guidance was raised in August, setting adjusted EPS expectations at $3.10 to $3.25 per share.

Earnings Context and Why It Matters

Avient is a global specialty materials and polymer formulator, organized around two reporting segments: Color, Additives and Inks, and Specialty Engineered Materials. The upcoming quarterly earnings release matters because it will test whether the company can sustain the momentum that lifted its second quarter results and prompted management to raise full-year guidance. Investors will look for confirmation that organic volume growth—not just pricing—is becoming the dominant growth driver, as executives signaled earlier this year. With exposure to electronics, healthcare, packaging, and transportation end markets, Avient's report also offers a broad read on industrial demand heading into the final months of 2026.

Earnings Expectations

Consensus estimates point to adjusted EPS of approximately $0.80 on revenue of roughly $857 million for the third quarter of 2026. That compares with adjusted EPS of $0.70 and sales of $806.5 million reported in the same period a year earlier. Management's own guidance for the quarter is aligned with the Street at about $0.80, representing roughly 14% year-over-year growth.

The expectations arrive on the heels of a standout second quarter, when Avient posted adjusted EPS of $0.96—about 20% above the prior year and ahead of the $0.89 consensus—while revenue rose 5.8% to $917 million. That performance prompted the company to lift its full-year 2026 outlook, including adjusted EPS guidance of $3.10 to $3.25 and adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) of $575 million to $603 million.

Investors will also watch how volume and price contribute to growth. In the second quarter, roughly three-quarters of organic growth came from pricing, but management expects that mix to flip toward volume as 2026 progresses. Transportation demand remains a known soft spot, while Asia has been a source of strength, with organic sales up 18% year over year last quarter.

AI Screener

For investors looking to track earnings events like Avient's and uncover similar opportunities, Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening, making it a useful companion for earnings-focused research and broader market analysis.

Market Reaction and Investor Sentiment

Sentiment heading into the third quarter report is broadly constructive. Avient shares have gained more than 25% over the past year, outpacing the broader specialty chemicals industry, and the stock has a history of positive post-earnings movement. The company has exceeded consensus EPS expectations in seven of the last eight quarters, which tends to keep investors optimistic ahead of the release.

Still, key risks could temper the reaction. Softness in transportation end markets, ongoing healthcare customer inventory rebalancing, and macroeconomic uncertainty around inflation and geopolitical developments all remain in focus. Because much of the recent growth has been pricing-driven, the market will be watching closely to confirm that volume growth is taking over—a shift management has said should become more evident in the back half of the year.

Forward Outlook and Key Factors to Monitor

Beyond the headline numbers, several factors will shape how investors interpret Avient's third quarter report and what comes next. The most important is the composition of organic growth. Management has indicated that volume should account for roughly 70% of organic growth by the fourth quarter, with pricing playing a smaller role. Confirming that trajectory would support the sustainability of recent results.

Margin performance is another key area. Avient achieved a record adjusted EBITDA margin of 18.3% in the second quarter, and investors will want to see whether that level can hold as pricing benefits moderate. Segment-level results—particularly in Specialty Engineered Materials, where EBITDA margins have expanded meaningfully—will offer clues about the durability of profitability gains.

Finally, balance sheet and capital allocation priorities matter. The company repaid $50 million of debt in the second quarter and is targeting $100 million to $150 million of total debt reduction in 2026, with a goal of reaching net leverage of 2.2 to 2.4 times by year-end. Progress on that front, along with any commentary on free cash flow and potential mergers and acquisitions (M&A) as leverage improves, will help investors gauge the company's longer-term flexibility.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations